Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Contec Bio: Quadrivalent Influenza Virus Split Vaccine Receives Drug Registration Certificate
Kangtai Biological announces that the four-valent influenza virus split vaccine developed by the company has received the “Drug Registration Certificate” issued by the National Medical Products Administration today.
The four-valent influenza virus split vaccine is suitable for people aged 3 and above, capable of stimulating the body’s immune response against influenza viruses, and is used to prevent influenza caused by vaccine-related strains of the influenza virus.